We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Tine Hansen

Tine Willum Hansen MD, PhD

Senior Researcher, Steno Diabetes Center, Copenhagen, Denmark

Dr. Hansen’s early research was centered on hypertension and risk stratification based on ambulatory blood pressure and arterial stiffness, having contributed significantly to this area, leading to seminal papers demonstrating the importance of ambulatory blood pressure assessment. In 2012, Dr. Hansen was appointed senior researcher at Steno Diabetes Center Copenhagen, this provided the unique opportunity to combine advanced imaging and clinical research in a high-risk population.

In 2013, Dr. Hansen initiated a study evaluating the cardiac microcirculation measured by PET/CT imaging and cardiac autonomic function using MIBG imaging in persons with type 2 diabetes. In 2016, a similar study in persons with type 1 diabetes was initiated and together these two studies have contributed to a new knowledge of the cardiac microvascular function. Dr. Hansen was awarded the Ascending Investigator Grant - Endocrinology & Metabolism from the Novo Nordisk Foundation in 2019. The project is designed with the primary aim to identify subpopulations at high risk of developing cardiovascular disease among asymptomatic persons with type 2 diabetes using advanced imaging modalities.

Disclosures

Dr. Hansen owns shares in Novo Nordisk A/S.